fluorescein-5-isothiocyanate has been researched along with naltrexone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, S; Bidlack, JM; el-Hamouly, W; Lawrence, DM; Leary, JF | 1 |
| Ansary, B; Dehpour, Ar; Karaji, AG; Khansari, N | 1 |
| Aung, HH; Li, XL; McEntee, E; Sun, S; Tong, R; Wang, CZ; Xie, JT; Yuan, CS | 1 |
3 other study(ies) available for fluorescein-5-isothiocyanate and naltrexone
| Article | Year |
|---|---|
Identification of kappa opioid receptors in the immune system by indirect immunofluorescence.
Topics: Acetamides; Amino Acid Sequence; Animals; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Immune System; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Naltrexone; Receptors, Opioid, kappa; Tumor Cells, Cultured | 1995 |
Detection of opioid receptors on murine lymphocytes by indirect immunofluorescence: mature normal and tumor bearing mice lymphocytes.
Topics: Animals; Avidin; Cell Line, Tumor; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Naltrexone; Narcotic Antagonists; Neoplasms, Experimental; Phycoerythrin; Receptors, Opioid; Spleen; T-Lymphocytes | 2005 |
Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Cyclin A; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorouracil; Humans; Lung Neoplasms; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Tumor Cells, Cultured | 2009 |